Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gerresheimer to acquire Blitz LuxCo Sarl, for EUR 800 million
Aquisition strengthens Gerresheimer’s position as a full - service provider in the pharma industry
Emcure and Gennova to resume mRNA collaboration with HDT
HDT has granted a license to Gennova to use HDT’s patented mRNA vaccine technology in multiple fields.
PharmaLytica Expo to be held on May 30, 2024
Organised by Informa Markets in India, this event marks its 10th edition, showcasing pharma ingredients, machinery, packaging,…
Biocon Biologics obtains USFDA approval for biosimilar Aflibercept
Yesafili enters U.S. market to treat ophthalmology conditions
Indoco Remedies gains USFDA approval for Pregabalin capsules
Generic version of Lyrica to be manufactured in Goa facility
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL
Sucralfate is used to treat stomach ulcers, GERD, radiation proctitis, and stomach inflammation and to prevent stress ulcers.
Alvotech and Dr Reddy’s collaborate on biosimilar AVT03
Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
Cipla gains USFDA approval for the generic version of Somatuline Depot (Lanreotide) injection
The new generic version to treat patients with GEP-NETs
AstraZeneca sets $80 billion revenue target by 2030
Company aims to launch 20 new medicines by 2030, and reduce carbon emissions
Sanofi, Formation Bio and OpenAI announce collaboration
The collaboration aim to build AI-powered software to accelerate drug development